Everest Organics Limited (EVERESTO.BO)
INR 257.5
(4.99%)
INR 257.5
(4.99%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 569.61 Million INR | 13.43% |
| 2022 | 502.18 Million INR | 31.71% |
| 2021 | 381.28 Million INR | 79.54% |
| 2020 | 212.37 Million INR | 33.26% |
| 2019 | 159.36 Million INR | -18.1% |
| 2018 | 194.59 Million INR | -9.95% |
| 2017 | 216.08 Million INR | 28.86% |
| 2016 | 167.69 Million INR | -36.97% |
| 2015 | 266.04 Million INR | 17.35% |
| 2014 | 226.72 Million INR | -8.61% |
| 2013 | 248.07 Million INR | 38.89% |
| 2012 | 178.6 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 562.78 Million INR | -1.2% |
| 2023 Q4 | 569.61 Million INR | 2.09% |
| 2023 Q1 | 543.5 Million INR | 8.23% |
| 2023 FY | 569.61 Million INR | 13.43% |
| 2023 Q3 | 557.96 Million INR | 8.41% |
| 2023 Q2 | 514.66 Million INR | -5.31% |
| 2022 Q3 | 366.09 Million INR | -7.61% |
| 2022 FY | 502.18 Million INR | 31.71% |
| 2022 Q2 | 396.26 Million INR | -3.34% |
| 2022 Q1 | 409.93 Million INR | 7.51% |
| 2022 Q4 | 502.18 Million INR | 37.17% |
| 2021 Q2 | 324.08 Million INR | 35.43% |
| 2021 Q1 | 239.3 Million INR | 12.68% |
| 2021 Q3 | 327.12 Million INR | 0.94% |
| 2021 FY | 381.28 Million INR | 79.54% |
| 2021 Q4 | 381.28 Million INR | 16.56% |
| 2020 Q1 | 227.85 Million INR | 13.68% |
| 2020 Q3 | 155.54 Million INR | -29.38% |
| 2020 Q4 | 212.37 Million INR | 36.53% |
| 2020 FY | 212.37 Million INR | 33.26% |
| 2020 Q2 | 220.25 Million INR | -3.33% |
| 2019 FY | 159.36 Million INR | -18.1% |
| 2019 Q3 | 11.76 Million INR | -94.41% |
| 2019 Q4 | 200.43 Million INR | 1603.85% |
| 2019 Q2 | 210.56 Million INR | -7.52% |
| 2019 Q1 | 227.67 Million INR | 1.4% |
| 2018 Q4 | 224.53 Million INR | 7.92% |
| 2018 FY | 194.59 Million INR | -9.95% |
| 2018 Q3 | 208.05 Million INR | -7.39% |
| 2018 Q2 | 224.65 Million INR | 5963.76% |
| 2018 Q1 | 3.7 Million INR | -98.33% |
| 2017 Q3 | 10.83 Million INR | -93.21% |
| 2017 Q1 | 14.91 Million INR | -91.93% |
| 2017 Q2 | 159.57 Million INR | 970.07% |
| 2017 Q4 | 221.37 Million INR | 1943.58% |
| 2017 FY | 216.08 Million INR | 28.86% |
| 2016 Q2 | 155.17 Million INR | 1362.45% |
| 2016 Q1 | 10.61 Million INR | -95.99% |
| 2016 Q4 | 184.78 Million INR | 0.0% |
| 2016 FY | 167.69 Million INR | -36.97% |
| 2015 Q4 | 264.53 Million INR | 0.0% |
| 2015 FY | 266.04 Million INR | 17.35% |
| 2014 FY | 226.72 Million INR | -8.61% |
| 2014 Q4 | 226.72 Million INR | 0.0% |
| 2013 Q2 | 141.49 Million INR | -1.3% |
| 2013 Q4 | 248.07 Million INR | 58.28% |
| 2013 Q1 | 143.35 Million INR | -19.74% |
| 2013 Q3 | 156.72 Million INR | 10.77% |
| 2013 FY | 248.07 Million INR | 38.89% |
| 2012 FY | 178.6 Million INR | 0.0% |
| 2012 Q4 | 178.6 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 114.62 Million INR | -396.933% |
| Checkpoint Trends Limited | -137.43 Thousand INR | 414575.734% |
| GUJARAT INJECT (KERALA) LTD. | -29.19 Million INR | 2051.334% |
| NATURO INDIABULL LIMITED | 118.7 Million INR | -379.849% |
| NEXUS SURGICAL AND MEDICARE LI | -2.34 Million INR | 24427.872% |
| Rajnish Wellness Limited | 46.89 Million INR | -1114.736% |
| Rama Vision Limited | 184.62 Million INR | -208.523% |
| Vivo Bio Tech Limited | 716.74 Million INR | 20.527% |